Arcoma AB (STO:ARCOMA)
Sweden · Delayed Price · Currency is SEK 8.00
-0.04 (-0.50%)
Sep 4, 2026, 11:25 AM CET
Arcoma AB Revenue
Arcoma AB had revenue of 32.10M SEK in the quarter ending June 30, 2026, a decrease of -15.86%. This brings the company's revenue in the last twelve months to 129.31M, down -6.23% year-over-year. In the year 2025, Arcoma AB had annual revenue of 132.62M, down -17.34%.
Revenue (ttm)
129.31M
Revenue Growth
-6.23%
P/S Ratio
0.90
Revenue / Employee
4.11M
Employees
31
Market Cap
114.47M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 132.62M | -27.83M | -17.34% |
| Dec 31, 2024 | 160.45M | -5.54M | -3.34% |
| Dec 31, 2023 | 165.99M | 36.11M | 27.80% |
| Dec 31, 2022 | 129.89M | 11.92M | 10.10% |
| Dec 31, 2021 | 117.97M | 63.00K | 0.05% |
| Dec 31, 2020 | 117.91M | -16.11M | -12.02% |
| Dec 31, 2019 | 134.01M | 14.51M | 12.14% |
| Dec 31, 2018 | 119.50M | 27.65M | 30.11% |
| Dec 31, 2017 | 91.85M | -10.23M | -10.02% |
| Dec 31, 2016 | 102.08M | -21.61M | -17.47% |
| Dec 31, 2015 | 123.69M | -6.84M | -5.24% |
| Dec 31, 2014 | 130.53M | 22.22M | 20.51% |
| Dec 31, 2013 | 108.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 461.29M |
| Integrum AB | 96.14M |
| ScandiDos AB | 54.22M |
| SciBase Holding AB | 52.40M |
| Promimic AB | 47.07M |
| Nosa Plugs AB | 31.84M |
| Clinical Laserthermia Systems AB | 12.56M |
| Acarix AB | 9.22M |
Arcoma AB News
- 15 days ago - Arcoma AB Quarterly report: Q2 2026 - Filings
- 4 months ago - Arcoma AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Arcoma AB Annual report: Q4 2025 - Filings
- 6 months ago - Arcoma AB Quarterly report: Q4 2025 - Filings
- 10 months ago - Arcoma AB Quarterly report: Q3 2025 - Filings